Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:12 AM UTC
| NCT Number | NCT07049926 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 140 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 16, 2026 (3 days ago) |
As of July 19, 2026: Clinical trial NCT07049926 is currently recruiting participants. This phase1 study for renal cell carcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07049926 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07049926 was last updated 3 days ago (July 16, 2026). HelloStudys verifies this status automatically.